C-ULRAArtan Bio
tRNA suppressors, codon suppression, nonsense mutation rescue
repairinggene therapy
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-ULRA
C-ULRAC-ULRAtRNA suppressors, codon suppression, nonsense mutation rescue
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Welcome to our series, DeSci Researcher AMA 🧬✨ This series is to give you a chance to hear firsthand from the researchers behind projects in the DeSci Space. Come and learn more about the science and get your questions answered — straight from the researchers themselves! 🗣️ Our session features two prestigious guests Daniel Bar with Tel Aviv University, and Michael Torres of Artan Bio.
VitaRNA by Artan Bio: https://vitarna.xyz Dive into an insightful panel discussion at DeSci Berlin with Michael Torres and Anthony Schwartz from VitaDAO, moderated by Logan Bishop-Currey from Molecule. Discover the transformative potential of Intellectual Property Tokens (IPTs) in the biotech industry as Michael and Anthony discuss their experiences with traditional fundraising methods versus innovative IPTs. Learn how Artan Bio leveraged IPTs to revolutionize funding mechanisms within the biotech sector, providing a fresh perspective on financing groundbreaking research. Logan Bishop-Currey: https://linkedin.com/in/logan-bishop-currey Anthony Schwartz: https://x.com/aschwartzphd/ Michael Torres: https://x.com/Mykalt45/ VitaDAO: https://www.vitadao.com/ Full DeSci Berlin 2024 Playlist: https://www.youtube.com/playlist?list=PLYCWARA8YNdqQs3wnZEYk-aPAxpbNv8e4 Join our Discord and let's discuss the future of #DeSci together. You can find all links below 👇🏼 ______ DeSci Berlin
The Lost and Damned'in bu sert ve duygusal final bölümünde, The Lost MC'nin kaderi bir kez ve tamamen mühürleniyor. Johnny Klebitz, artık geri dönülemez bir yolda. Elizabeta Torres'in artan paranoyası ve polis baskısıyla son işler sarpa sararken, eski sevgili Ashley'nin bitmek bilmeyen sorunları Johnny'yi Rus mafyasının ve hain planların tam ortasına çekiyor. Ray Boccino'nun ayak oyunları ve Billy Grey'in hapisten çıkıp tanık koruma programına girmek için Johnny'yi satmaya kalkışması, bardağı taşıran son damla oluyor. Johnny, kalan son sadık kardeşleri Terry ve Clay ile birlikte, haini kendi oyununda vurmak için Alderney Eyalet Hapishanesi'ne ölümcül bir baskın düzenliyor. Ancak ihanetin bedeli ağır oluyor; dostluklar paramparça oluyor ve Johnny, bir zamanlar uğruna yaşadığı her şeyi temsil eden o karanlık kulüp binasını kendi elleriyle ateşe veriyor. Kardeşlik, sadakat ve kaybedilen her şey üzerine bu dokunaklı final, Lost MC'nin hikayesini alevler içinde sonlandırıyor. Discord'a gel
Cali Yare Cali - A HERO'S WELCOME Omar Abdulkadir Artan Facebook Log In Cali Yare Cali's Post
The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ The incidence of HLA-DQ2/DQ8 in Turkish children with celiac disease and a comparison of the geographical distribution of HLA-DQ Prz Gastroenterol . 2017;12(4):256-261. doi: 10.5114/pg.2017.72099. Epub 2017 Dec 14. Authors Ahmet Basturk 1 , Reha Artan 1 , Aygen Yilmaz 1 Affiliation 1 Department of Paediatric Gastroenterology, Faculty of Medicine, Akdeniz University, Antalya, Turkey. PMID: 29358994 PMCID: PMC5771449 DOI: 10.5114/pg.201
Appreciate Molecule and VitaDAO allowing me and the ARTAN Bio team to share our story of building a crypto-funded longevity focused biotech. It’s actually really cool! Anthony Schwartz Brian Bodemann | Michael Torres LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices a
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
INTRODUCING VitaRNA by Artan Bio | VitaDAO WHY LONGEVITY RESEARCH VITA LABS VITA TOKEN PROJECTS BLOG STORE GET VITA LOADING Back to the blog Reading Mode Dark Light 23 MAY 2024 3 min read Projects INTRODUCING VitaRNA by Artan Bio Tokenizing the Artan Bio IP-NFT On this page Meet the team The VitaRNA Story VITARNA Tokemics About the IPT crowdsale VitaDAO i s tokenizing the ArtanBIO IP-NFT , a gene therapy project , with a goal of raising $300,000 for research advancement. Crowdsale link : https://vitarna.xyz In exchange, the community will be granted voting power to govern the IP, and participa … g and capital allocation. For the first time, a community is coming together to fund and steer innovative research for a single treatment addressing multiple aspects of ageing. ArtanBIO is exploring the promising field of gene therapies that could help address aging-related genetic factors. The Company’s approach aims to develop therapeutic candidates that could potentially suppress mutations that may drive aging. ARTAN is led by two entrepreneurs who have led advanced drug d … al support for Artan Bio, via a Sponsored Research Agreement (SRA), has been to fund the design and validation of their engineered suppressor system (VDP-103) in cells with targetable mutations to confirm validity of the approach. Artan Bio seeks to continue development of the engineered suppressor system beyond the initial project with VitaDAO to further the IP development, and further validate the system in animal models to support preclinical translation and establish a de
Discover Blog Resources About Launch App Connect Company Blog Resources About Brand Assets Careers Ecosystem Bio Protocol Biofy BIOS DeSci Codes Pept.ai Subscribe By subscribing you agree to our Privacy Policy and Terms of Service © 2026 Molecule. All rights reserved. Privacy Policy Terms of Service Artan Bio Advances Nonsense Mutation Research Through Democratized Funding via Molecule’s IP Protocol | Molecule Back to Blog Overview Artan Bio Advances Nonsense Mutation Research Through Democratized Funding via Molecule’s IP Protocol An important research milestone was reached — data showed Arta … t late last year when the VitaDAO community used Molecule’s IP-NFT framework to fund $91,300 worth of work for developing and testing tRNA suppressors in cells with specific mutations. This funding led to the creation of in vitro assays and the development of 15 potential drug candidates. Since then, the VitaDAO community has further supported Artan Bio through a successful crowdsale of IP Tokens, raising an additional $300,000 USD in 10 days ( token ticker: $VitaRNA ). . The … -102, the lead candidate, and more extensive studies in animals. Artan Bio will submit a proposal to VITARNA tokenholders to support the feasibility study. This will produce high-quality material sufficient for safety and efficacy studies; critical experiments are needed before testing in humans is possible. If all goes well, this innovative approach could one day help treat or even cure diseases caused by DNA mutations, such as neurodegeneration and cancer. What Artan Bio … ements— it is proof that decentralized communities can come together to quickly fund and advance innovative research that otherwise would have laid dormant. By using new technologies to democratize funding and create new incentive mechanisms, Artan Bio has not only advanced our scientific understanding of mutations in aging but has moved us one step closer to the transparent and inclusive vision of decentralized science.
Tommaso Busoni and Artan Marku — 2700 km on Skateboard - Italian Outdoor Festival Skip to content Oct 24—25, 2026 Milan FREE TICKET Schedule Events Where We Are Contact Us Gallery Best Store Oct 24—25, 2026 Milan JOIN Schedule Events Where We Are Contact Us Gallery Best Outdoor Store Skateboard | Talk Tommaso Busoni and Artan Marku — 2700 km on Skateboard What Talk Category Skateboard Adventures When Saturday, May 9, 26 2:00 PM → 3:00 PM Duration 60 minutes WHERE BASE Milano Wild Stage AVAILABLE SPOTS 50 PRICE Free Registration required Tommaso Busoni and Artan Marku, independent filmmakers an
--> ARTAN BIO | tRNA Suppressors for Rare Diseases and Aging top of page Next-generation Codon Suppressors for Rare Diseases and Aging ARTAN is a biotechnology company developing a novel approach to address genetic and age-related diseases caused by nonsense mutations. These mutations lead to premature protein translation stops, resulting in incomplete and nonfunctional proteins. Our pipeline involves an engineered suppressor system that specifically recognizes these codons and restores normal protein translation. View our 2026 Investor Presentation Our Team Anthony Schwartz, PhD Chief E
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Advertisement Artan R. Hoxha's biography 'Enver Hoxha' is a plodding portrait of a Marxist tyrant Sign In Home News Politics White House Senate House Campaigns Policy 2026 Election Opinion Editorials Op-Eds In Focus Restoring America Magazine Watch Sponsored Powering Progress ASAE – Association Leadership Examining Tax Reform Fix TSCA National Parks Inside the Corn Belt Examining Transportation TWS Archive Search Washington Examiner Subscribe Search Washington Examiner Sign in Subscribe News Politics Trump Administration White House Senate House Campaigns Business World In
Fixing Genetic Glitches: ARTAN Bio's DeSci-Fueled War on Aging - BriefGlance.com Skip to main content BriefGlance.com INTELLIGENCE Intelligence Market pulse Wire Media Center Contact Sign In Menu × Intelligence Market pulse Wire Media Center Contact Sign In Home James Green Fixing Genetic Glitches: ARTAN Bio's DeSci-Fueled War on Aging Fixing Genetic Glitches: ARTAN Bio's DeSci-Fueled War on Aging 📊 Key Data $200,000 seed round raised via VitaDAO, a decentralized funding model for biotech innovation. 10% of genetic diseases caused by nonsense mutations, targeted by ARTAN Bio … disruptive innovation and connections to a venture network actively seeking to fund the genomic revolution. The credibility of the leadership team further strengthens its position. Dr. Schwartz brings a serial entrepreneur’s track record, having founded over a dozen startups and navigated a product through FDA approval. Dr. Torres provides deep scientific expertise, having co-founded ReCode Therapeutics, a clinical-stage genetic medicines company that raised over $300 millio … Revenue CAGR Related Articles BC’s Life Sciences Sector Flexes Muscle with 2026 Award Slate The Hughes Report Kardium’s landmark FDA win and a new wave of innovators signal a biotech boom, cementing British ... 7 days ago The $4B Signal: How a Side Effect Became Pharma's Next Gold Rush Mark Peterson A forgotten corner of oncology is set for a 14.2% CAGR. A new wave of drugs for chemo-induced neu... 9 days ago Pay in the AI Era: Tech Transforms Compensation into a Strategi
VITARNA - Tokenization of the ArtanBio IPNFT About VITARNA story Tokenomics Roadmap Whitepaper Sale Info About VITARNA story Tokenomics Roadmap Sale Info Get $VITARNA This website uses cookies to improve your browsing experience. Please read our Privacy Policy for more information on what information we gather and how it is used. Preferences Deny All Accept All Privacy Preferences Essential cookies Required Marketing cookies Essential Personalization cookies Essential Analytics cookies Essential Reject all cookies Allow all cookies Save preferences VitaRNA by Artan Bio VitaRNA - the tokenizati … NA Telegram About VITARNA For the first time, a community is coming together to fund and steer innovative research for a single treatment addressing multiple aspects of aging. Artan Bio is exploring the promising field of gene therapies that could help address aging-related genetic factors. The company’s approach aims to develop therapeutic candidates that could potentially suppress mutations that drive aging. Artan Bio is led by two entrepreneurs who have previously advanced … al support for Artan Bio, via a Sponsored Research Agreement (SRA), has been to fund the design and validation of their engineered suppressor system (VDP-103) in cells with targetable mutations to confirm validity of the approach. Artan Bio seeks to continue development of the engineered suppressor system beyond the initial project with VitaDAO to further the IP development, and further validate the system in animal models to support preclinical translation and establish a de … evelopment candidate for use in clinical trials. May 2023 The Artan Bio funding application is submitted Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur blandit fringilla consectetur. Morbi at arcu odio. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. July 2023 Funding for Artan Bio via IP-NFT successfully approved by $VITA token holders Lorem ipsum dolor sit amet, consectetur adipiscing elit. Curabitur blandit fr
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
N. Sertac Artan | New York Tech Search Admissions & Aid Admissions & Aid Admissions & Aid Home First-Year Students Transfer Students Graduate Students Veteran Students International Students Tuition & Financial Aid Contact Us Apply Apply Now Academics Academics Academics Home Degrees Colleges & Schools Courses Advising Academic Calendar Academic Success Honors College Innovation and Entrepreneurship Academy Libraries Classes, Schedules & Transcripts (Registrar) Career Success & Experiential Education Experiential Learning All Degrees Student Life Student Life Studen … 's New Current Students Faculty & Staff Alumni Vancouver Request Info Visit Apply Give Staff & Faculty Directory Home > Directory > N. Sertac Artan N. Sertac Artan Associate Professor; Electrical & Computer Engineering, College of Engineering & Computing Sciences Associate Professor; , College of Engineering & Computing Sciences Education Credentials: Ph.D. Joined New York Tech: 2014 N. Sertac Artan is an Associate Professor of Electrical and Computer Engineering at … ty of the New York University School of Engineering. He also worked as an ASIC (Application Specific Integrated Circuit) Design Engineer and designed integrated circuits for commercial, academic and military applications. Dr. Artan is the co-chair of the National Workshop for REU Research in Networking and Systems (REUNS) since 2021. He also served in the organizing committees of the ACM/IEEE Symposium on Architectures for Networking and Communications Systems (ANCS), IEEE Sa … rch in Networking and Systems , Denver, CO, Oct. 21, 2022 (Best Paper Runner-up Award). S. Senbel, S. Sharma, M. S. Raval, C. Taber, J. Nolan, N. S. Artan, D. Ezzeddine, and T. Kaya. “Impact of Sleep and Training on Game Performance and Injury in Division-1 Women’s Basketball amidst the Pandemic,” IEEE Access, Volume 5, Jan. 2022. Kunyu Sun, N. Sertac Artan, and Ziqian Dong, “CALC: Calibration for Ambient Light Correction in Screen-to-Camera Visible Light Communic
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
Our Team - Artan Technologies | Cybersecurity, Cloud, and Digital Solutions Artan Technologies | Cybersecurity, Cloud, and Digital Solutions About Us Our Team Our Services Consulting & Advisory ISO27001 & ISO42001 Consulting Cybersecurity Risk Management Cloud Security Risk & Controls Standards & Framework Implementation Audit & Assessments Internal Audits Cloud Security Risk Assessment Regulatory Risk & Compliance Assessment Vulnerability Assessments & Pen Testing Managed Security and On-Demand Expertise Managed Security Operations Center (MSOC) Managed Threat and … curity training programs and risk mitigation initiatives, helping organizations apply cybersecurity frameworks effectively in real-world scenarios. Ishan Thakur Principal Consultant Ishan is a Principal Consultant at Artan Consulting with over 8 years of experience. He specializes in security automation, SASE, incident response programs, and SOC implementation. Holding a Master’s in Cybersecurity, Ishan is skilled in network security, vulnerability management, SIEM, SOAR, and
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Michael ARTAN - Talent Acquisition Specialist - HEVERETT GROUP Ce site Web utilise des cookies pour vous garantir la meilleure expérience. HEVERETT GROUP et nos partenaires sélectionnés utilisent des cookies et des technologies similaires (ensemble, les « cookies ») qui sont nécessaires pour vous présenter ce site Web, et pour vous garantir la meilleure expérience. Si vous y consentez, nous utiliserons également des cookies à des fins de statistiques. Consultez notre politique relative aux cookies pour en savoir plus sur les cookies que nous utilisons. Vous pouvez retirer et modifier votre con
Evaluation of skill-acquisition process in mitral valve repair techniques: a simulation-based study Evaluation of skill-acquisition process in mitral valve repair techniques: a simulation-based study J Surg Educ . 2013 May-Jun;70(3):318-25. doi: 10.1016/j.jsurg.2013.01.009. Authors Murat Tavlasoglu 1 , Ahmet Baris Durukan , Zekeriya Arslan , Mustafa Kurkluoglu , Anar Amrahov , Artan Jahollari Affiliation 1 Diyarbakir Military Medical Hospital, Department of Cardiovascular Surgery, Diyarbakır, Turkey. [email protected] PMID: 23618440 DOI: 10.1016/j.jsurg.201 … ion, Medical, Graduate / methods* Educational Measurement Humans Internship and Residency Mitral Valve / surgery* Task Performance and Analysis Video Recording
ARTAN Bio Raises $200K for Nonsense Mutations Treatment | Jesse Landry posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agre … ing, DNA Sequencing, Synthetic Cells, Bioinformatics, CRISPR Technologies ➡️ By Application: Drug Discovery & Development, Cell & Gene Therapy, Vaccine Development, Diagnostics, Regenerative Medicine, Tissue Engineering ➡️ By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes, Academic Centers, Contract Research Organizations (CROs) ➡️ By Region: North America, Europe, Asia-Pacific, South America, Middle East & Africa 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲�
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
World Cup referee Omar Artan will receive full fee from FIFA despite being denied entry to the US Skip to content News TV6 Live Latest Videos First Alert Weather TV6 Investigates Sports Upper Michigan Today Submit Photos Obituaries Community Calendar Home News TV6 Morning News TV6 Investigates National State Politics Election Results Sports Latest Sports Video Scoreboard U.P. Power! Spotlight U.P. Power! Podcast National Sports First Alert Weather Winters past, present and future Safety Guide Radar Maps Storm Reports Weather Happenings What's Up With The Weather? Podcasts Between the Line … able Conversations The UPside Aging Untold Someplace Special Community Calendar Submit Photos & Video Contact Us Meet the Team TV6 Careers Sign up for TV6 Newsletters Get the TV6 Apps Advertise Social Media Policy Newsletter Closings NextGen TV Obituaries Webcams Advertise with Us Sponsorship Submission Form Birthday Club Craft Show Schedule Pets Circle Country Local News Live InvestigateTV Watching Your Wallet PowerNation Digital Marketing Gray AI Policy World Cup refere
ARTAN Bio Raises $200,000 in Decentralized Funding to Advance Longevity Science Through Mutation-Specific Codon Suppression | FirstWord PHARMA You need to enable JavaScript to run this app. Loading...
TheGrio - Referee Omar Artan has been appointed by UEFA to... Facebook Log In TheGrio's Post TheGrio Verified account June 14 at 11:01 AM · Shared with Public Referee Omar Artan has been appointed by UEFA to officiate next season’s UEFA Super Cup after being denied entry into the United States and removed from the officiating team for the 2026 FIFA World Cup. The Somali official, widely regarded as one of Africa’s top referees, will now oversee one of Europe’s premier club matches. The appointment is being viewed as a major recognition of Artan’s experience, achievements, and standing in
Somali referee Omar Artan lands a sponsorship deal - TRT Afrika | English | English POLITICS AFRICA TÜRKİYE OPINION FEATURES SPORTS SPORTS 1 min read Somali referee Omar Artan lands a sponsorship deal Somali referee Omar Artan's deal with Dahabshiil Group is meant to support sports development and inspire young people in Somalia, the firm said. Share Somali referee Omar Artan (left) during the signing of the deal with Dahabshiil Group. / Others By Nuri Aden Somali referee Omar Artan has signed a sponsorship deal with Somali remittance and financial services firm Dahabshiil Group. The firm
Qatar Stars League (QSL) Signs Sponsorship Agreement with Artan Holding - Artan Holding Please rotate your device! This page is best viewed in Portrait orientation EN About Us Management Team Our Companies News Careers Partnership Contact Us Home About Us Management Team Our Companies News Careers Partnership Contact Us Phone: (+974) 4403 8666 Fax: (+974) 4412 3799 E-Mail: [email protected] 30 Jun 2025 Qatar Stars League (QSL) Signs Sponsorship Agreement with Artan Holding In a new step towards continuing to develop commercial and marketing aspects, the Qatar Stars League (QSL) anno
Qatar Stars League signs sponsorship agreement with Artan Holding - CUQ Ulster University Apply Online Register to Learn More Contact Us ✕ No results See all results العربية English ✕ Home About Us Our Vision & Mission Vice Chancellor’s Message President’s Message Ulster Partnership Accreditations Our Team Our Campus An ACES Institute Programmes Our UK Degrees and Pathways International Foundation Programme Undergraduate Degrees Postgraduate Degrees BTEC Higher National Diploma General Prospectus Admissions How to Apply Tuition & Fees Apply Online International Students T … duate Degrees BTEC Higher National Diploma General Prospectus Admissions How to Apply Tuition & Fees Apply Online International Students Testing Centre IELTS Student Experience Student Life at CUQ Academic Schedule Student Handbook International Students Library Student Portal Alumni CUQ Brings Tech to Life: High School Students Explore Electronics in Hands-On Lab 30/06/2025 Cyprus Ambassador Visits City University Qatar 07/09/2025 CUQ Brings Tech to Life: High School St … Terms & Policies Terms & Conditions Privacy Policy Fee Policy Useful Links Apply Online Register to Learn More Contact Us Visit Us City University Qatar Building No 39 Street 255 Zone 69, Erkiyah PO Box 200197 Lusail, Qatar Find our campus on the map Download Prospectus Contact Us Phone: 00974 4019 8198 Email: [email protected] University Hours: Sundays to Thursdays 8:00 am – 8:00 pm Administration Hours: 8:00 am - 5:00 pm WhatsApp Us Tiktok @CUQULSTER Facebook @CUQ
ARTAN Bio Completes $200k Seed Raise for Aging Disease Suppressor | Startup Researcher North America posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continu … neered suppressor tRNA system to restore protein function. The new capital will fund validation in animal models. More at: https://lnkd.in/ez24eZiM #Biotech #Longevity #Funding 4 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in More Relevant Posts Bas Verhagen 1w Edited Report this post For years, the debate on genetic modification has been pushed using a fear-based, non-scientific agenda with a specific goal in mind, stopping progress. It's good … Skeleton Key . The round also saw new investors Merck Global Health Innovation Fund and CQDM , and existing investors Real Ventures and Anges Québec . Alison Hirukawa | Ann Lai | Hugo Sinha #DropGenie #biotechnology #funding #startupnews #businessnews #businessupdate 2 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Startup Rise USA News 11,064 followers 2d Report this post DropGenie , a Montreal, Canada- and Boston, MA-based biotechnology compa … Skeleton Key . The round also saw new investors Merck Global Health Innovation Fund and CQDM , and existing investors Real Ventures and Anges Québec . Alison Hirukawa | Ann Lai | Hugo Sinha 🔗 Read full article link in comment #DropGenie #biotechnology #funding #startupnews #businessnews #businessupdate 4 1 Comment Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in Sawan Kumar Das 1w Report this post 🧬 CRISPR-Cas9: The Genetic Scissors Revolutioni … althcare #Agriculture #BiotechFor "What do you think will be the most impactful application of CRISPR-Cas9 in the next decade?" View C2PA information 11 Like Comment Share Copy LinkedIn Facebook X To view or add a comment, sign in 2,577 followers View Profile Connect Explore content categories Career Productivity Finance Soft Skills & Emotion
I’m really excited by what Jay Rosanelli and team are building and have built at Syenex. One of my companies, ARTAN Bio, has an ongoing collaboration in the HSC space. After spending time with… | Michael Torres LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any
Artan Biotechnologies LLC - Page 1 | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health China's GLP-1 landscape PFA re-energizes afib mark … 26 No Comments Artan Biotechnologies LLC has completed a $200,000 seed raise to fund preclinical advancement of the company’s proprietary engineered suppressor platform, which targets nonsense mutations. Read More Popular Stories Today's news in brief BioWorld BioWorld briefs for June 24, 2026. Have brain-computer interfaces finally arrived? BioWorld More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that ca
Discover Blog Resources About Launch App Connect Company Blog Resources About Brand Assets Careers Ecosystem Bio Protocol Biofy BIOS DeSci Codes Pept.ai Subscribe By subscribing you agree to our Privacy Policy and Terms of Service © 2026 Molecule. All rights reserved. Privacy Policy Terms of Service Mutation-Specific Codon Suppression for Aging and Longevity | Molecule Website Snapshot X Telegram Mutation-specific Codon Suppression for Aging and Longevity VITARNA Gene Therapy Artan Bio has proposed a novel approach to address genetic and age-related diseases caused by nonsense mutations. These
Building ARTAN Bio with Crypto and VitaDAO | Michael Torres posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, you agree to Linked … is really cool and it was the perfect use-case for funding through a longevity fund VitaDAO which has it’s own token. We’ll officially be announcing more soon, but I’m personally investing $1M to continue moving the science forward. As folks know how I build I companies, it’s all about the team and being capital efficient. I’ll be announcing hires soon! Anthony Schwartz Moe Wehbe Bio Protocol 2,623 followers 2w Michael Torres just sold CrossBridge Bio to Eli Lilly for up to
--> ASGCT 2026: Michael Torres isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play top of page Home Quick Takes Around Kendall Science Spotlight BiotechTV U Company News Bright Minds Shows Biotech Direct BioVenture VoiCes Biotech CEO Sisterhood The Studio at Kendall Square Off-Target Effects with Matt Gline Tech + Tours ASGCT 2026: Michael Torres isn't slowing down after selling his antibody-drug conjugate company to Eli Lilly. Here's his gene therapy play May 14 1 min read He describes the work he is involved in with ARTAN
ARTAN Bio Completes Seed Raise for ARTAN-102 Suppressor tRNA Platform | Anthony Schwartz posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or
JavaScript is disabled In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.
ARTAN Bio - Mutation-Specific Codon Suppression for Aging and Longevity | VitaDAO WHY LONGEVITY RESEARCH VITA LABS VITA TOKEN PROJECTS BLOG STORE GET VITA LOADING IP-NFT A VITADAO PROJECT ARTAN Bio - Mutation-Specific Codon Suppression for Aging and Longevity age related diseases cancer nonsense suppression IP-NFT Funding $91,300 Initiated 02.08.2023 Anthony Schwartz, Ph.D Project Manager Michael Torres, Ph.D. Principal Investigator AT A GLANCE Stage : Early stage preclinical discovery PROJECT LINKS View governance proposal View on-chain vote Funding $91,300 Initiated 02.08.2023 Anthony Schwar … GLANCE Stage : Early stage preclinical discovery PROJECT LINKS View governance proposal View on-chain vote ARTAN is a biotechnology company developing first-in-class interventions to tackle the most frequent nonsense mutations implicated in a wide range of age-related diseases and cancers. These nonsense mutations induce premature stops of protein translation when occurring in coding regions. Background Nonsense mutations, alterations in the DNA or RNA sequence that produce … eline ARTAN Bio begins with a project kickoff meeting following approval of the proposal. Phase 1 involves designing and generating a nonsense suppression construct for use in an AAV vector. Upon completion, phase 1 results are presented in a meeting or quarterly review, and a "go/no-go" decision is made. If the project progresses, phase 2 commences, focusing on in vitro testing of selected vectors and oligos. Phase 2 concludes with a presentation of results and a proposition
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Artan Group – International Trading Company Skip to content About Us Our Subdiaries Our Sectors Contact Us Search for: Search Artan Group International Trading Company About Us Our Subdiaries Our Sectors Contact Us Search for: Search Artan Trading Consulting and Investment Business We honored to provide Fast & High quality services to our esteemed customers and our customer list is proof of this commitment. Meanwhile, we could offer investment consultant and usance LC to our clients too. Artan Steel Steel Trading Company Our Main Business Is Import & Export of Raw & Industrial Materials
EX-10.1 2 ex10-1.htm EXHIBIT 10.1 Exhibit 10-1 ASSIGNMENT In consideration for the issuance of 1,777,778 fully paid and assessable restricted shares of common stock of Bearing Mineral Exploration, Inc., a Nevada corporation and other good and valuable consideration, receipt of which is hereby acknowledged, Art Agolli (the “Assignor”) hereby sell, assign, transfer, and convey to Bearing Mineral Exploration, Inc, a Nevada corporation, (the “Assignee”) all of Assignor’s right, title, and interest in and to that certain Letter Of Intent between Assignor … Sonic Reactor ”) and technology and that the Corporation has developed an application utilizing the Sonic Reactor for the treatment and upgrading of heavy oil by sonicated solvent de-asphalting. We understand that the Sonic Reactors are constructed by a third party supplier with the designs provided by the Corporation. For the purposes hereof, all of the Corporation’s designs, trade secrets, know how, process and application for the use of the Sonic Reactor for th … class in the authorized capital of AlbaniaCo; (b) Authorize AlbaniaCo to grant an option or right to any person or party to purchase any un-issued securities of any class in the authorized capital of AlbaniaCo; (c) Authorize AlbaniaCo to enter into any material contracts with any person or party other than in the ordinary course of business; (d) Pledge, lease, dispose, encumber or grant to any person or party, any interest in any of t … p; (f) Authorize or be party to any transaction to pledge, dispose, encumber or grant to any person or party, any interest in and to the AlbaniaCo Shares, or any part thereof; and (g) Pledge, lease, dispose, encumber or grant to any person or party, any interest or licence in the Technology. 10.0 Due Diligence and Confidentiality 10.1 Upon execution by the parties of this Letter of Intent and until the Closing Date, the Corporation shall allow the Purchas
Michael ARTAN - Talent Acquisition Specialist - AXEAL This website uses cookies to ensure you get the best experience. AXEAL and our selected partners use cookies and similar technologies (together “cookies”) that are necessary to present this website, and to ensure you get the best experience of it. If you consent to it, we will also use cookies for analytics purposes. See our Cookie Policy to read more about the cookies we set. You can withdraw and manage your consent at any time, by clicking “Manage cookies” at the bottom of each website page. Accept all cookies Decline all non-necessary co
Artan Shipping | Maritime & Shipping Services Loading... Skip to content Artan Shipping Maritime & Shipping Services فارسی Menu Home About Us Services Port Agency Ship Chartering Ship Sale & Purchase Crew Management Naval Architecture & Marine Engineering Supply Export Materials Mineral Materials Supply Petrochemical Materials Supply Resources Our Projects Contact Us Providing All Technical Documents Cargo & Chartering Providing cargo for all types of cargo vessels for chartering & Supply vessels for all Exporters and Importers. Ship Sale & Purchase Introducing, c
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
Instagram See everyday moments from your close friends . Log into Instagram Mobile number, username or email Password Log in Forgot password? Log in with Facebook Create new account Meta About Blog Jobs Help API Privacy Terms Locations Popular Instagram Lite Meta AI Threads Contact Uploading & Non-Users Meta Verified English Down chevron icon Afrikaans العربية Čeština Dansk Deutsch Ελληνικά English English (UK) Español (España) Español فارسی Suomi Français עברית Bahasa Indonesia Italiano 日本語 한국어 Bahasa Melayu Norsk Nederlands Polski Português (Brasil) Português (Portugal) Русский Svenska ภ
ARTAN Bio Raises $200,000 in Decentralized Funding to Advance Longevity Science Through Mutation-Specific Codon Suppression Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia Ga … lorida, today announced the completion of a $200,000 seed raise. The raise will fund preclinical advancement of ARTAN Bio's proprietary engineered suppressor platform, which targets nonsense mutations — a class of genetic errors responsible for premature protein translation stops that underlie a wide range of aging-related and genetic diseases. About the Technology ARTAN Bio has developed a novel engineered suppressor tRNA system (ARTAN-102) designed to selectively recognize … RTAN Bio's mutation-specific platform offers a targeted strategy with potential application across multiple aging-associated conditions. The company has successfully completed initial in-cell validation of ARTAN-102 via an earlier seed raise with VitaDAO . Proceeds from the raise will fund the next stage of development, including validation of the suppressor system in animal models, advancement toward a preclinical development candidate, and intellectual property filings to p … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
VitaRNA Q4 Progress: First Tokenized Gene Therapy Scales to Production, 2025 Eyes Animal Studies | VitaDAO WHY LONGEVITY RESEARCH VITA LABS VITA TOKEN PROJECTS BLOG STORE GET VITA LOADING Back to the blog Reading Mode Dark Light 24 OCTOBER 2024 2 min read Projects VitaRNA Q4 Progress: First Tokenized Gene Therapy Scales to Production, 2025 Eyes Animal Studies In a significant update on October 24, 2024, VitaRNA/Artan Bio showcased continued advancement in their groundbreaking approach to treating genetic diseases and aging-related conditions. On this page Recent achievements include: Q4 2024:
Molecule Discover Blog Resources About Launch App Connect Company Blog Resources About Brand Assets Careers Ecosystem Bio Protocol Biofy BIOS DeSci Codes Pept.ai Subscribe By subscribing you agree to our Privacy Policy and Terms of Service © 2026 Molecule. All rights reserved. Privacy Policy Terms of Service
Browse Jobs at Funded Startups Job Board by Nonlinear Jobs Companies Departments Feature Your Jobs A free resource by The Nonlinear Project Jobs at recently funded startups, updated daily. Feature Your Jobs Subscribe to the Newsletter © 2026 The Nonlinear Project The Nonlinear Project / Job Board Jobs at the funded startups building what's next. Thousands of roles, scraped daily from 16,896 + live job pages. No recruiter spam. No paywalls. From The Nonlinear Project , a space for anyone figuring out what comes next in their career. Search jobs Filter by company All Companies 'Ôrəbell … y Agronomy All All Company All Departments All Functions All Teams API Platform Application (Interest) Applied Architect Arizona Warehouse Art Artificial Intelligence Asset Hub Assets and Investments Associates Assortiment Automation Autonomy Autonomy & Algorithms B2B Barista Battle Road Digital BD Beauty Bezorger Biology Brand Brand & Communications Browser Builders Bunker Business 16,896 job s found Obstetrician/Gynecologist (PRN) New Diana Health · Dallas-fort Wort
Partnership Announcement with Artan Consulting | TRECCERT GmbH Certifications OUR CERTIFICATIONS Information Security Artificial Intelligence Compliance Environmental Management Quality Management Anti-Bribery Risk Management Need to prepare for these certifications? TRECCERT offers training materials, practice exams, quizzes, and exercises to help you deepen your knowledge and pursue your certification goals. Audit Business Continuity Data Protection DORA ISRM Other Need to prepare for these certifications? TRECCERT offers training materials, practice exams, quizzes, and exercises to help you … rtified Globally recognized credentials Enhanced career opportunities Practical application of standards Preparation Training Programs E-Learning Network Partner Network Become a Partner Become a Trainer Corporate Training TRECCERT Chile About Who are We WHO ARE WE About TRECCERT Business Principles Accreditation Statement Organizational Structure Contact Us Certification Resources CERTIFICATION RESOURCES Certification Process Certification Rules and Policies Examin … rtified Globally recognized credentials Enhanced career opportunities Practical application of standards Preparation Training Programs E-Learning Network Partner Network Become a Partner Become a Trainer Corporate Training TRECCERT Chile About Who are We WHO ARE WE About TRECCERT Business Principles Accreditation Statement Organizational Structure Contact Us Certification Resources CERTIFICATION RESOURCES Certification Process Certification Rules and Policies Examin
VDP-164 VitaDAO Funding Proposal: $500K Loan to Advance VITARNA Through Non-GLP Toxicology Toward 2026 IND Submission - Proposals - Governance Forum | VitaDAO = 40rem)" rel="stylesheet" data-target="desktop" /> = 40rem)" rel="stylesheet" data-target="discourse-ai_desktop" /> = 40rem)" rel="stylesheet" data-target="discourse-reactions_desktop" /> = 40rem)" rel="stylesheet" data-target="poll_desktop" /> = 40rem)" rel="stylesheet" data-target="desktop_theme" data-theme-id="3" data-theme-name="sam's simple theme"/> Governance Forum | VitaDAO VDP-164 VitaDAO Funding Proposal: $500K Loan to Adva … mates (early 2026), complete the full IND-enabling package throughout 2026, and submit to regulators for clinical trial authorization. The pre-IND meeting is planned for Q1 2026, allowing incorporation of regulatory feedback into the GLP study design. This positions the company for IND submission in late 2026 and first-in-human trials by early 2027. Strategic Expansion & UAE Initiative VITARNA is exploring strategic opportunities in the UAE that could accelerate developme … ta in hand we can continue to explore efficacy models while going after the big prize…testing in humans. I know you follow me on Twitter, so I assume you’ve seen the papers I’ve been sharing related to biology and the MOA we’re working on. SB23 January 18, 2026, 2:44pm 7 VCs will not pay back a loan out of future financings – we’d only get paid back at an exit event. If I’m an early stage VC and there’s a 5M financing round, there’s no way I would let 10% of that round get pa … execution and governance perspective, I present a structured assessment of the proposal in light of established practices in biotech financing and pre-IND development. The objective is not to slow execution, but to align funding with oversight mechanisms consistent with institutional standards observed in advanced preclinical programs. From the standpoint of DAOOps (Execution Intelligence layer), I have identified several areas where a structured conversation could strengthe … 3(R2) guidelines. 2. Regulatory Strategy and Jurisdictional Transferability The proposal references clinical discussions in Abu Dhabi alongside preparation for a US IND submission in 2026. Clarifying whether Abu Dhabi represents a parallel validation path, a phased strategy, or a jurisdiction-specific approach would reduce regulatory ambiguity. A
2023 Simons Collaboration on New Structures in Low-Dimensional Topology Annual Meeting You are using an outdated browser. Please upgrade your browser to improve your experience. Simons Foundation chevron-down--small Program Areas Mathematics & Physical Sciences Life Sciences Autism Research Initiative Neuroscience Simons Collaborations Flatiron Institute Science, Society & Culture Multidisciplinary Programs Funding Funding Opportunities Policies and Procedures Award Instructions Simons Award Manager (SAM) FAQs and Videos News Announcements Articles Videos What We’re Reading Events … iences Funding Request for Applications Programs Policies and Procedures Simons Award Manager (SAM) FAQ and Instructional Videos News Events Conferences Symposia About About Us Scientific Advisory Board Home Mathematics & Physical Sciences Events 2023 Simons Collaboration on New Structures in Low-Dimensional Topology Annual Meeting Date March 30 - 31, 2023 Organizers: Aaron Lauda, University of Southern California Sergei Gukov, Caltech Speakers: Sergei Gukov, Caltech Pete … er Opportunities Funding Funding Opportunities Policies & Procedures Simons Award Manager Simons Foundation International Programs Life Sciences Autism Research Neuroscience Collaborations Mathematics & Physical Sciences Science, Society & Culture Stay Connected Newsletter Events Media Relations Terms & Conditions Privacy Policy © Simons Foundation Program Areas Program Areas Mathematics & Physical Sciences Mathematics & Physical Sciences Mathemat … iences Funding Request for Applications Programs Policies and Procedures Simons Award Manager (SAM) FAQ and Instructional Videos News Events Events Conferences Symposia About About About Us Scientific Advisory Board Life Sciences Life Sciences Life Sciences Research Areas Ecology and Evolution Plant Biology Microbial Ecology & Evolution Microbial Oceanography Funding Funding Funding Opportunities Life Sciences Awards Project Awards Funding Policies Simons Award Manager (SAM) … ence Neuroscience Funding Funding Funding Fellows-to-Faculty Fellows-to-Faculty Apply Fellows Funding Community SURFiN Fellowship SURFiN Fellowship Apply Here The SURFiN Community About Us Simons Collaborations Simons Collaborations Simons Collaborations Life Sciences Collaborations Life Sciences Collaborations Life Sciences Collaborations Resear
%PDF-1.4 %���� 2300 0 obj > endobj xref 2300 251 0000000016 00000 n 0000006912 00000 n 0000007096 00000 n 0000011698 00000 n 0000011813 00000 n 0000013541 00000 n 0000015491 00000 n 0000015606 00000 n 0000015734 00000 n 0000015935 00000 n 0000016085 00000 n 0000016235 00000 n 0000018186 00000 n 0000020254 00000 n 0000021944 00000 n 0000022094 00000 n 0000022244 00000 n 0000022343 00000 n 0000022501 00000 n 0000022651 00000 n 0000022766 00000 n 0000022885 00000 n 0000023010 00000 n 0000023135 00000 n 0000023260 00000 n 0000023385 00000 n 0000023561 00000 n 0000023711 00000 n 0000023830 00000 n … 2447 0 obj > endobj 2448 0 obj > endobj 2449 0 obj > endobj 2450 0 obj >stream application/pdf PAAR26_logo 2026-03-09T15:17:54-05:00 2026-03-09T15:17:54-05:00 2026-03-09T15:17:54-05:00 Adobe Illustrator 30.2 (Macintosh) uuid:96a9437f-47a4-4a48-a7e8-9b052a55103f xmp.did:22516fd4-ac5d-4f04-bfbb-042ec85b9ce2 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:739c2912-cb7f-d34a-badd-1fa118429d56 xmp.did:459394a8-c086-45dc-a1be-3b5c69f1c230 uuid:5D20892493BFDB11914A8590D31508C8 … ��� ��� endstream endobj 67 0 obj > endobj 68 0 obj > endobj 69 0 obj >stream application/pdf PAAR26_icon 2026-02-26T13:04:30-06:00 2026-02-26T13:04:30-06:00 2026-02-26T13:04:30-06:00 Adobe Illustrator 30.2 (Macintosh) uuid:07e45244-c7fe-7e43-acad-5f03bcb9458e xmp.did:636ac6fd-6390-4a6c-ac1a-7d83acb495e5 uuid:5D20892493BFDB11914A8590D31508C8 proof:pdf uuid:ae95be65-7cc5-744b-a7a0-1fe2c202f956 xmp.did:22516fd4-ac5d-4f04-bfbb-042ec85b9ce2 uuid:5D20892493BFDB11914A8590D31508C8 … �|q�7G�v��HB�[��\�jyM_/;\� ca� ��ǧsjqmjFPWj ���,�hɸ� 1e7�N�� ��ı�9���%|�RfpМ���T0m�!��Sp�y!O�/$u�B�U�2}ь{ �e�*:#w gN�#Q&�A"䞀u�#�9�%F[�̂}1 ��aM���Ͼ�O��W�q�v/ |Bo���sK��@�wqć�c�}J; 8�26�q�f ��(`�[���l 9�6�� ��T�X ���l)�5��RM�'X���rS�"�R$���#�c���f �K0�5��zȚI� ����Dy�T�Ta�f��>X�T�7�wz3��(�jY���_���[�{��8�Ɲ�[+�Fɻb�&̋=I�s3D�$qf �8�Ǟz�cJ�gm�H��Eչ!�ǛV�M�T�Q,h�{wb]���9'��-�"�����K����>��QWפKaOL���b��p=��q���F�dH��Ia�3)a~�T����%_i�y���:{� l��0���aSR … ����x��p=F �A���#�f��]����p���P `� H endstream endobj 206 0 obj >stream application/postscript DEED Flat Irma Mercado Adobe Illustrator CC (Windows) 2016-09-21T15:25:50-05:00 2016-09-21T15:25:51-05:00 2016-09-21T15:25:51-05:00 proof:pdf uuid:65E6390686CF11DBA6E2D887CEACB407 xmp.did:04888aed-a036-2c4d-979c-cb6da7880154 xmp.iid:04888aed-a03
Tietosuojavalintasi guce guce Tietosuojasi on meille tärkeää Tietosuojavalintojasi käytetään kaikissa Yahoo-konsernin tarjoamissa sivustoissa ja sovelluksissa. Yahoo käyttää evästekäytännöstämme ."> Evästeet Evästeiden (sekä vastaavien tekniikoiden, esimerkiksi verkkotallennuksen) avulla verkkosivustojen sovellusten ylläpitäjät voivat tallentaa ja lukea laitteesi tietoja. Lue lisää evästekäytännöstämme . evästeitä seuraaviin tarkoituksiin: tarjotaksemme sivustomme ja sovelluksemme sinulle todentaaksemme käyttäjät, estääksemme roskapostia ja väärinkäytöksiä sekä toteuttaaksemme tietoturvatoimia
ARTAN Bio Collaborates with Syenex VivoCell for Precision Delivery of Codon Suppressors for Aging Products Data Feature Plans Request Demo Sign Up for Free ARTAN Bio Collaborates with Syenex VivoCell for Precision Delivery of Codon Suppressors for Aging 2 July 2025 HOUSTON and CHICAGO, June 30, 2025 – ARTAN Bio , a biotechnology company focused on creating therapies to counteract epigenetic changes linked to aging and related diseases, has announced a new partnership with Syenex . Syenex is a genetic medicines platform company known for its advanced precision delivery technologies. The collabo … of-of-concept to studies necessary to support an investigational new drug (IND) application. This progression is intended to be achieved in a capital-efficient manner. Dr. Michael Torres, Co-Founder and Chief Scientific Officer of ARTAN Bio, emphasized the importance of precise delivery systems to unlock the full potential of ARTAN-102. He noted Syenex’s expertise in innovative delivery solutions and manufacturing scalability, which positions them as an ideal partner as ARTAN
342700694-10-30-2025-59-AS-CRAK-DMXTHA-20251030144425 <meta name="robots" content="noindex"> Department of SOCIAL SERVICES Community Care Licensing FACILITY EVALUATION REPORT Facility Number: 342700694 Report Date: 10/30/2025 Date Signed: 10/30/2025 02:44:34 PM Document Has Been Signed on 10/30/2025 02:44 PM - It Cannot Be Edited STATE OF CALIFORNIA - HEALTH AND HUMAN SERVICES AGENCY FACILITY EVALUATION REPORT CALIFORNIA DEPARTMENT OF SOCIAL SERVICES COMMUNITY CARE LICENSING DIVISION SACRAMENTO NORTH ASC , 9835 GOETHE ROAD, SUITE 100 SACRAMENTO , CA 95827 FACILITY NAM … any disagreement in this report with the licensing agency concerning the proper application of licensing requirements. The applicant/ licensee may request a formal review by the licensing agency to amend or dismiss the notice of deficiency and/ or civil penalty. Requests for review shall be made in writing within 15 business days of receipt of a deficiency notification or civil penalty assessment. Licensing deficiencies may be appealed pursuant to the procedures in the LIC 90
--> ARTAN BIO | tRNA Suppressors for Rare Diseases and Aging top of page Next-generation Codon Suppressors for Rare Diseases and Aging ARTAN is a biotechnology company developing a novel approach to address genetic and age-related diseases caused by nonsense mutations. These mutations lead to premature protein translation stops, resulting in incomplete and nonfunctional proteins. Our pipeline involves an engineered suppressor system that specifically recognizes these codons and restores normal protein translation. View our 2026 Investor Presentation Our Team Anthony Schwartz, PhD Chief E
ARTAN Bio Partners with Syenex VivoCell Platform for Precision in vivo Delivery of Next-Generation Codon Suppressors for Aging Accessibility Statement Skip Navigation Resources Investor Relations Journalists Agencies Client Login Send a Release News Products Contact Search Search When typing in this field, a list of search results will appear and be automatically updated as you type. Searching for your content... No results found. Please change your search terms and try again. News in Focus Browse News Releases All News Releases All Public Company English-only News Releases Overview Multimedia … tform Login ProfNet Data Privacy Do not sell or share my personal information : Submit via [email protected] Call Privacy toll-free: 877-297-8921 Contact PR Newswire Products About My Services All News Releases Platform Login ProfNet Call PR Newswire at 888-776-0942 Terms of Use Privacy Policy Information Security Policy Site Map RSS Cookies Copyright © 2026 Cision US Inc. --> -->
Seed funding at Artan Bio supports work on aging | BioWorld BioWorld. Link to homepage. BioWorld BioWorld Science BioWorld Asia Data Snapshots Biopharma Medical technology Infographics: Dynamic digital data analysis Index insights NME Digest Special reports Infographics: Dynamic digital data analysis BCI Ebola outbreak Hantavirus Trump administration impacts Med-tech outlook 2026 Under threat: mRNA vaccine research BioWorld at 35 Biopharma M&A scorecard Bioworld 2025 review BioWorld MedTech 2025 review BioWorld Science 2025 review Women's health China's GLP-1 landscape PFA re-energ … 26 No Comments Artan Biotechnologies LLC has completed a $200,000 seed raise to fund preclinical advancement of the company’s proprietary engineered suppressor platform, which targets nonsense mutations. BioWorld Science Financings Aging Seed Popular Stories Today's news in brief BioWorld BioWorld briefs for June 24, 2026. Have brain-computer interfaces finally arrived? BioWorld More and more individuals now have chronically implanted brain-computer interface (BCI) systems in
What if a single therapy could validate the entire aging thesis? Michael Torres explains how VITARNA from ARTAN Bio is built to hit a huge disease target, and open new doors in longevity. Watch the… | Molecule LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any t
VITARNA's Progress in Targeting Age-Related Mutations VitaDAO’s Substack Subscribe Sign in VITARNA's Progress in Targeting Age-Related Mutations VitaDAO Sep 06, 2024 Share In a recent data drop on July 26, 2024, Artan Bio shared significant progress in its innovative approach to combating genetic diseases and aging. Funded by VitaDAO ($91k) as an IP-NFT and raising over $300k through the tokenization of the Artan Bio IP-NFT, the biotech startup is developing tRNA suppressors targeting nonsense mutations linked to these conditions. Led by CEO Anthony Schwartz and CSO Michael Torres , Artan … an be packaged in a gene therapy vector. The company plans for its next funding proposal within one month to support the scale-up of the candidates for use in animal efficacy and safety studies. As Artan Bio progresses, it emphasizes community engagement while considering future funding options. This work could open new avenues in treating genetic diseases and addressing fundamental causes of aging, promising a healthier future for all. To watch the full data drop presentatio
ARTAN Bio's Vision for Biotech and Crypto Convergence | Anthony Schwartz posted on the topic | LinkedIn LinkedIn respects your privacy LinkedIn and 3rd parties use essential and non-essential cookies to provide, secure, analyze and improve our Services, and to show you relevant ads (including professional and job ads ) on and off LinkedIn. Learn more in our Cookie Policy . Select Accept to consent or Reject to decline non-essential cookies for this use. You can update your choices at any time in your settings . Accept Reject Agree & Join LinkedIn By clicking Continue to join or sign in, yo
We’re excited to welcome ARTAN... - Spark Labs by ARK Invest Facebook Log In Spark Labs by ARK Invest's Post Spark Labs by ARK Invest 1d · Shared with Public We’re excited to welcome ARTAN Bio to spARK Labs by ARK Invest Co-Founder & CEO Anthony Schwartz, Ph.D., shared, “spARK Labs offers exactly the kind of community and infrastructure that early-stage tech and biotech companies need to move from idea conception to commercialization. We’re building at the intersection of rare disease, oncology, and longevity, and we’re excited to be surrounded by other founders with similar ambitions